| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Salicylic acid 60 mg/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| Lactic acid 40 mg/g and salicylic acid 120 mg/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| Salicylic acid 110 mg/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| salicylsyragel |
Has manufactured dose form |
False |
Cutaneous gel |
Inferred relationship |
Some |
|
| bensoylperoxid 100 mikrogram/milligram, kutan gel |
Has manufactured dose form |
False |
Cutaneous gel |
Inferred relationship |
Some |
|
| Product containing precisely metronidazole 7.5 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| metronidazol, gel |
Has manufactured dose form |
False |
Cutaneous gel |
Inferred relationship |
Some |
|
| Product containing precisely metronidazole 8 milligram/1 milliliter conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| Metronidazole 10 mg/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| Product containing precisely adapalene 1 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| Product containing precisely tetracaine 40 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| Tetracaine hydrochloride 20 mg/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| Product containing precisely clindamycin (as clindamycin phosphate) 10 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| bensoylperoxid 2,5 % + klindamycin 1,2 %, gel för lokalt bruk |
Has manufactured dose form |
False |
Cutaneous gel |
Inferred relationship |
Some |
|
| klindamycin 1,2 % / tretinoin 0,025 %, gel för lokalt bruk |
Has manufactured dose form |
False |
Cutaneous gel |
Inferred relationship |
Some |
|
| Polynoxylin 100 mg/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| Adapalene 3 mg/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| Adapalene 1 mg/g and benzoyl peroxide 25 mg/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| Diclofenac sodium 30 mg/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| Ibuprofen 50 mg/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| Product containing precisely ketoprofen 25 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| Product containing precisely piroxicam 5 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| Ibuprofen 100 mg/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| Fluocinolone acetonide 250 microgram/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| Benzalkonium 2.5 mg/g and polyethylene 219 mg/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| Tretinoin 100 microgram/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| Product containing precisely tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| Product containing precisely erythromycin 20 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| Product containing precisely erythromycin 40 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| Product containing precisely nicotinamide 40 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| Product containing precisely benzoyl peroxide 100 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| Product containing precisely benzoyl peroxide 50 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| Product containing precisely fusidic acid 20 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| Product containing precisely heparinoid 3 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| Lidocaine hydrochloride 5 mg/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| Lidocaine hydrochloride 10 mg/mL cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| Product containing precisely lidocaine hydrochloride 20 milligram/1 milliliter conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| Product containing precisely calcium gluconate 25 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| Product containing precisely isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| adapalen 1 mikrogram/milligram, kutan gel |
Has manufactured dose form |
False |
Cutaneous gel |
Inferred relationship |
Some |
|
| Product containing precisely becaplermin 100 microgram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| Desoximetasone 500 microgram/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| testosteron 1 %, gel |
Has manufactured dose form |
False |
Cutaneous gel |
Inferred relationship |
Some |
|
| Tretinoin 1 mg/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| deoximetason 0,5 %, gel |
Has manufactured dose form |
False |
Cutaneous gel |
Inferred relationship |
Some |
|
| Fluocinonide 500 microgram/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| betametasondipropionat 0,05 %, gel |
Has manufactured dose form |
False |
Cutaneous gel |
Inferred relationship |
Some |
|
| Clobetasol propionate 500 microgram/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| Product containing precisely ibuprofen 50 milligram/1 gram and levomenthol 30 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| testosteron 50 mg, gel 5 g, dospåse |
Has manufactured dose form |
False |
Cutaneous gel |
Inferred relationship |
Some |
|
| Product containing precisely benzoyl peroxide 50 milligram/1 gram and clindamycin (as clindamycin phosphate) 10 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| terbinafinhydroklorid 1 %, gel |
Has manufactured dose form |
False |
Cutaneous gel |
Inferred relationship |
Some |
|
| Tretinoin 400 microgram/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| Lidocaine hydrochloride 20 mg/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| Azelaic acid 150 mg/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| Dapsone 50 mg/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| Desonide 500 microgram/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| Ketoconazole 20 mg/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| Product containing precisely bexarotene 10 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| Oxybutynin hydrochloride 100 mg/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| Product containing precisely tazarotene 1 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| Product containing precisely benzoyl peroxide 25 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| Product containing precisely dithranol 2.5 milligram/1 gram and salicylic acid 16 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| Coal tar 50 mg/g and pine tar 50 mg/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| Tazarotene 500 microgram/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| Diclofenac diethylammonium 11.6 mg/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| Estradiol 600 microgram/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| Testosterone 10 mg/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| Clindamycin phosphate 12 mg/g and tretinoin 250 microgram/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| Product containing precisely benzoyl peroxide 25 milligram/1 gram and clindamycin phosphate 12 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| Terbinafine (as terbinafine hydrochloride) 10 mg/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| Product containing precisely chlorhexidine (as chlorhexidine gluconate) 40 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| Product containing precisely silver nanoparticle 20 microgram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| Diclofenac sodium 10 mg/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| Product containing precisely testosterone 20 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| Testosterone 16.2 mg/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| Product containing precisely estradiol 1 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| Diclofenac sodium (as diclofenac diethylammonium) 20 mg/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| Carbenoxolone 20 mg/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| Product containing precisely etofenamate 50 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| Brimonidine (as brimonidine tartrate) 3.3 mg/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| Diclofenac sodium (as diclofenac diethylammonium) 10 mg/g cutaneous gel |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|
| Product containing precisely clindamycin (as clindamycin phosphate) 10 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
True |
Cutaneous gel |
Inferred relationship |
Some |
|